Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer

This publication has 40 references indexed in Scilit:

• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Thymidylate Synthase Protein Expression in Primary Colorectal Cancer: Lack of Correlation With Outcome and Response to Fluorouracil in Metastatic Disease Sites
  Journal of Clinical Oncology, 2003
• Prognostic Value of Thymidylate Synthase, Ki-67, and p53 in Patients With Dukes’ B and C Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study
  Journal of Clinical Oncology, 2003
• p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer
  British Journal of Surgery, 2002
• High‐frequency microsatellite instability predicts better chemosensitivity to high‐dose 5‐fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection
  International Journal of Cancer, 2002
• GENETIC AND EPIGENETIC ALTERATIONS IN COLON CANCER
  Annual Review of Genomics and Human Genetics, 2002
• Ki‐ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer
  The Journal of Pathology, 2001
• Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
  New England Journal of Medicine, 2001
• Dihydropyrimidine Dehydrogenase Activity and Thymidylate Synthase Level Are Associated with Response to 5-fluorouracil in Human Colorectal Cancer.
  The Kurume Medical Journal, 2001
• The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry
  JNCI Journal of the National Cancer Institute, 1996